ICD-10 Code A18.2 | Tuberculous peripheral lymphadenopathy Symptoms, Diagnosis, Billing

Tuberculous peripheral lymphadenopathy is a condition characterized by the enlargement of lymph nodes due to Mycobacterium tuberculosis infection. It is clinically significant as it can indicate disseminated tuberculosis and may require prompt diagnosis and treatment. The ICD-10 Code A18.2 facilitates accurate documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this infectious disease.

What is ICD-10 Code A18.2 for Tuberculous peripheral lymphadenopathy?

ICD-10 Code A18.2 represents Tuberculous peripheral lymphadenopathy, which occurs when the lymph nodes become infected with tuberculosis bacteria. This code should be used in clinical documentation and billing when a patient presents with swollen peripheral lymph nodes due to tuberculosis, indicating a need for targeted treatment and monitoring of the underlying disease.

ICD-10 Code A18.2 – Clinical Definition and Explanation of Tuberculous peripheral lymphadenopathy

Tuberculous peripheral lymphadenopathy is primarily caused by the spread of Mycobacterium tuberculosis through the lymphatic system. It can progress to more severe forms of tuberculosis if not treated promptly, necessitating medical intervention. Early recognition and treatment are crucial to prevent complications and further transmission.

Key Clinical Features:

• Swollen, tender lymph nodes, often in the neck or axilla.
• Possible systemic symptoms such as fever, night sweats, and weight loss.
• History of exposure to tuberculosis or previous infection.
• Diagnostic imaging may reveal lymphadenopathy and associated findings.

ICD-10 Code A18.2 for Tuberculous peripheral lymphadenopathy – SOAP Notes & Clinical Use

ICD-10 Code A18.2 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plan for Tuberculous peripheral lymphadenopathy. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation and continuity of care.

What Does ICD-10 Code A18.2 for Tuberculous peripheral lymphadenopathy Mean in SOAP Notes?

In SOAP notes, ICD-10 Code A18.2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Tuberculous peripheral lymphadenopathy. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code A18.2 – Tuberculous peripheral lymphadenopathy

Tuberculous peripheral lymphadenopathy requires prompt medical attention, often necessitating hospitalization for severe cases. Treatment typically involves antibiotic therapy to combat the infection.

Antibiotic Therapy:

• First-line: Isoniazid, Rifampin, Pyrazinamide, Ethambutol for 6-12 months.
• Alternative: Streptomycin or Levofloxacin for resistant cases.
• Duration: Typically 6-12 months depending on clinical response.

Supportive Care:

• Pain management with analgesics.
• Nutritional support to enhance recovery.
• Monitoring for potential complications such as abscess formation.

Infection Control:

• Implement airborne precautions in healthcare settings.
• Educate patients on hygiene practices to prevent transmission.
• Screen close contacts for tuberculosis infection.

How to Document Symptoms of Tuberculous peripheral lymphadenopathy (ICD-10 A18.2) in SOAP Notes

Subjective:

• Patient reports swollen lymph nodes in the neck.
• Complaints of night sweats and unintentional weight loss.
• History of recent exposure to a tuberculosis-positive individual.
• Experiencing fatigue and low-grade fever.

Objective:

• Physical examination reveals enlarged, tender lymph nodes.
• Vital signs: Temperature 100.5°F, pulse 88 bpm, respiratory rate 16.
• Chest X-ray shows no active pulmonary disease.
• Laboratory tests indicate elevated ESR and positive tuberculin skin test.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Tuberculous peripheral lymphadenopathy (ICD-10 Code A18.2)

Assessment:

• Diagnosis: Tuberculous peripheral lymphadenopathy, moderate severity.
• ICD-10 Code: A18.2.
• Contributing factors: Recent exposure to tuberculosis.
• Consider differential diagnoses such as lymphoma or other infections.

Plan:

• Initiate first-line antibiotic therapy: Isoniazid and Rifampin.
• Educate patient on medication adherence and potential side effects.
• Schedule follow-up in 1 month to assess treatment response.
• Consider referral to infectious disease specialist if no improvement.

Treatment & Plan Section for ICD-10 Code A18.2 – Tuberculous peripheral lymphadenopathy

• First-line pharmacologic treatments include Isoniazid and Rifampin.
• Non-pharmacologic strategies involve nutritional support and hydration.
• Monitoring includes regular follow-up appointments and laboratory tests.
• Patient education on tuberculosis transmission and treatment adherence.

Using ICD-10 Code A18.2 for Tuberculous peripheral lymphadenopathy in Billing & SOAP Note Compliance

• Select appropriate ICD-10 code based on clinical findings and documentation.
• Ensure Subjective (S) and Objective (O) sections reflect the diagnosis accurately.
• Align treatment plans with clinical guidelines to support justified billing.
• Document any relevant CPT codes for services rendered alongside A18.2.

Related ICD-10 Codes Often Used with Tuberculous peripheral lymphadenopathy

• A15.0 – Pulmonary tuberculosis, bacteriologically and histologically confirmed
• A19.9 – Tuberculosis, unspecified

ICD-10 Code A18.2 in Medical Billing and Insurance for Tuberculous peripheral lymphadenopathy

ICD-10 Code A18.2 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of A18.2.
• Use this code in conjunction with other codes for comprehensive billing.
• Ensure that the treatment plan aligns with the diagnosis for reimbursement.
• Include detailed notes on patient education and follow-up care.

Common CPT Pairings: